# OnCo record array-biopharma (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/array-biopharma/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "array-biopharma" ;
  schema:name "Array BioPharma"@en ;
  schema:alternateName "Array BioPharma Inc."@en, "NASDAQ:ARRY"@en ;
  schema:description "Array BioPharma, of Boulder, Colorado, developed encorafenib and binimetinib, two pills taken together for melanoma with a BRAF mutation. Pfizer bought the company in 2019."@en ;
  schema:url <https://onco.cc/companies/array-biopharma/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.sec.gov/Archives/edgar/data/1100412/000110465919035823/a19-11481_1ex99d1.htm>, <https://www.sec.gov/Archives/edgar/data/1100412/000119312519206255/d733992d8k.htm> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/colorectal/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/braf/>, <https://onco.cc/targets/mek/> ;
  onco:drugs <https://onco.cc/drugs/encorafenib/>, <https://onco.cc/drugs/binimetinib/> .